Skip to main content
Skip to content
Case File
efta-efta00369258DOJ Data Set 9Other

From: "Jeffrey E." <[email protected]>

Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00369258
Pages
2
Persons
0
Integrity
No Hash Available

Summary

Ask AI About This Document

0Share
PostReddit

Extracted Text (OCR)

EFTA Disclosure
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: "Jeffrey E." <[email protected]> To: Lesley Groff Subject: Re: Confidential Date: Wed, 21 May 2014 13:31:43 +0000 im not in ny until june but happy to see you both after On Wed, May 21, 2014 at 9:28 AM, Lesley Groff •MIIMIa wrote: Begin forwarded message: From: "James Meiskin" < Subject: FW: Confidential Date: May 21, 2014 9:23:58 AM EDT To: < Reply-To: < Jeffrey, David Carter (Company information is attached), is in NY today and tomorrow moming, and I felt that it could be beneficial and timely for you to further learn about this opportunity if there was interest on your end. Please take a moment to review the attached material. and let me know if you would like to meet while David is in NYC. Best Regards, James Dear James, Like I have said in an earlier email. I am looking for an "investing partner" to match (50%/50%) the money Russian Venture Capital plans to invest in USA based Biotechnology. They will provide half of the capital to develop a variety of technologies that are of interest to their country. For their investment they get commercialization rights to the technologies they finance for Russia and the CIS. For us, on the USA side, this is a major source of capital to start a series of companies that have great potential as therapeutic technologies, and we get commercialization rights for the USA, and rest of the world markets. Basically, we get the rights that are valuable to us at "half price". Over the next several years our plan is to identify seven/eight technologies that are worthy of development. RVC has already agreed to finance the first (MAI') and is looking at the next two—Prediction Biosciences, and OvationBio. I have several more currently in diligence. (The original Investor Presentation made in Moscow is attached) So, I am looking for a source of capital that thinks this is an interesting investment theme, and is willing to consider the idea as something they might want to implement. My belief is that there is more money in NYC, seeking an investment home, then there are "quality investment ideas". I could be wrong, but I have to believe that people running a lot of capital in New York would want to hear new, creative, and GOOD new investment ideas. I think this idea is the kind of idea that is worth a look, and worth serious consideration. I think we are talking $150M over a five year horizon. Best, David David W. Carter EFTA00369258 President—DaCart Capital LLC please note The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of JEE Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return e-mail or by e-mail to [email protected], and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved EFTA00369259

Technical Artifacts (1)

View in Artifacts Browser

Email addresses, URLs, phone numbers, and other technical indicators extracted from this document.

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.

Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.